Evidence map›Paper›PMID 27542215›Full record

ArticleOncotarget2016

Zbtb1 prevents default myeloid differentiation of lymphoid-primed multipotent progenitors.

Xianyu Zhang, Ying Lu, Xin Cao, Tao Zhen, Damian Kovalovsky

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Zbtb1 controls NKp46Oncotarget · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Xianyu ZhangExperimental Immunology Branch, NCI, NIH, Maryland, USA.
Ying LuExperimental Immunology Branch, NCI, NIH, Maryland, USA.
Xin CaoCollege of Life Science and Engineering, Northwest University for Nationalities, Gansu Engineering Research Center for Animal Cell, Lanzhou, China.
Tao ZhenOncogenesis and Development Section, National Human Genome Research Institute, NIH, Maryland, USA.
Damian KovalovskyExperimental Immunology Branch, NCI, NIH, Maryland, USA.
National Human Genome Research Institute · USNorthwest Minzu University · CN

Funding

Zbtb family members in lymphocyte differentiation and functionZIABC011429 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KOVALOVSKY, DAMIAN · 2012 to 2017
$3.4M
Intramural NIH HHS ZIA BC011429
6 · The paper itself

Abstract

Zbtb1 is a transcription factor that prevents DNA damage and p53-mediated apoptosis in replicating immune progenitors, affecting lymphoid as well as myeloid development when hematopoietic progenitors are in competition in mixed bone marrow chimeras. However, Zbtb1-deficient mice do not have an apparent myeloid deficiency. We report here that Zbtb1-deficient lymphoid-primed multipotent progenitors (LMPPs) are biased to develop towards the myeloid fate in detriment of lymphoid development, contributing to the apparent unaffected myeloid development. Zbtb1 expression was maintained during lymphoid development of LMPP cells but downregulated during myeloid development. Deficiency of Zbtb1 in LMPP cells was sufficient to direct a myeloid fate in lymphoid-inducing conditions and in the absence of myeloid cytokines as shown by upregulation of a myeloid gene signature and the generation of myeloid cells in vitro. Finally, biased myeloid differentiation of Zbtb1-deficient LMPP cells was not due to increased p53-dependent apoptosis as it was not reverted by transgenic Bcl2 expression or p53 deficiency. Altogether, our results show that Zbtb1 expression prevents activation of a default myeloid program in LMPP cells, ensuring the generation of lymphoid cells.

Indexed as

AnimalsApoptosisCell DifferentiationCell LineageCells, CulturedDNA DamageGene Expression RegulationHematopoiesisLymphocytesLymphoid Progenitor CellsMiceMice, KnockoutMyeloid CellsMyeloid Progenitor CellsRepressor ProteinsTumor Suppressor Protein p53Repressor ProteinsTumor Suppressor Protein p53ZBTB1 protein, mousedevelopmentdifferentiationImmune responseImmunityImmunology and Microbiology SectionlymphoidmyeloidZbtb1

Identifiers

PMID27542215
PMCPMC5312274
OpenAlexW2508682760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.